|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.71 USD | -2.37% |
|
-0.40% | +3.06% |
| 05-15 | NeuroMetrix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-19 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
NeuroMetrix, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 1.09 million compared to USD 1.72 million a year ago. Net loss was USD 3.03 million compared to USD 1.57 million a year ago.
Basic loss per share from continuing operations was USD 1.67 compared to USD 1.64 a year ago. Diluted loss per share from continuing operations was USD 1.67 compared to USD 1.64 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +3.06% | 7.46M | |
| -4.16% | 184B | |
| -2.39% | 103B | |
| -4.08% | 67.59B | |
| +16.04% | 46.93B | |
| -11.10% | 43.87B | |
| +8.28% | 41.2B | |
| +17.63% | 30.47B | |
| -8.10% | 23.57B | |
| +13.59% | 24.16B |
NEUROMETRIX, INC. 
